Boronic acid and nitrofuranyl derivatives as potential therapeutics

Boronic acid and nitrofuranyl derivatives as potential therapeutics

Chapter 1 commences with a brief panorama of antibacterial development from the very first modern antibacterial agent, namely Salvarsan® to the very last class of clinically significant antibacterials, namely oxazolidinones. It then goes on to briefly outline the practice of modern Drug Design under...

Bibliografski detalji
Glavni autor:	Dey, AL
Daljnji autori:	Schofield, CJ
Format:	Disertacija
Jezik:	English
Izdano:	2021
Teme:	Medicinal Chemistry Drugs > Design

Slični predmeti

Boron in Medicinal Chemistry: Powerful, but Neglected
od: Patrick Mäder
Izdano: (2019-08-01)

Synthesis and mechanistic analyses of boron-containing β-lactamase inhibitors
od: Krajnc, A
Izdano: (2020)

Modelagem Molecular: Uma Ferramenta para o Planejamento Racional de Fármacos em Química Medicinal Molecular modeling: a tool for rational drug design in medicinal chemistry
od: Eliezer J. Barreiro, i dr.
Izdano: (1997-06-01)

26th Annual GP2A Medicinal Chemistry Conference & 32nd Journées Franco-Belges de Pharmacochimie
od: Patrick Dallemagne, i dr.
Izdano: (2019-05-01)

Os produtos naturais e a química medicinal moderna
od: Viegas Jr Cláudio, i dr.
Izdano: (2006-01-01)

Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary
od: Shujing Xu, i dr.
Izdano: (2022-01-01)

Molecular Modeling for Drug Design
od: Rainer Metternich
Izdano: (2000-01-01)

Review on the potential of 1,3,4-Oxadiazine derivatives: Synthesis, structure-activity relationship, and future prospects in drug development
od: Saleem Akbar, i dr.
Izdano: (2024-08-01)

Application of Chiral Piperidine Scaffolds in Drug Design
od: Qiu-Shi Chen, i dr.
Izdano: (2023-03-01)

The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry
od: Katia Messner, i dr.
Izdano: (2022-02-01)

Therapeutic potential of selenium and tellurium compounds: opportunities yet unrealised
od: Tiekink, E.R.T.
Izdano: (2012)

Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
od: Ri Han, i dr.
Izdano: (2023-09-01)

Advances and Perspectives in Applying Deep Learning for Drug Design and Discovery
od: Celio F. Lipinski, i dr.
Izdano: (2019-11-01)

Investigating the Prospects of ChatGPT in Training Medicinal Chemists and the Development of Novel Drugs
od: Michell O. Almeida, i dr.
Izdano: (2024-12-01)

The art of drug synthesis/
od: Johnson, Douglas S., i dr.
Izdano: (2007)

Click Reactions and Boronic Acids: Applications, Issues, and Potential Solutions
od: Chaofeng Dai, i dr.
Izdano: (2010-08-01)

Silicon Nanotubes as Potential Therapeutic Platforms
od: Nguyen T. Le, i dr.
Izdano: (2019-11-01)

Biodiversidade: fonte potencial para a descoberta de fármacos Biodiversity: potential source for drug discovery
od: Eliezer J. Barreiro, i dr.
Izdano: (2009-01-01)

Atropisomeric fragments in drug discovery and probe compound development
od: Danet, B
Izdano: (2022)

INTERAÇÕES FÁRMACO-RECEPTOR: APLICAÇÕES DE TÉCNICAS COMPUTACIONAIS EM AULA PRÁTICA SOBRE A EVOLUÇÃO DOS INIBIDORES DA ENZIMA CONVERSORA DE ANGIOTENSINA
od: Maurício Temotheo Tavares, i dr.
Izdano: (2015-09-01)

25th Conference of GP2A
od: Michael D. Threadgill, i dr.
Izdano: (2017-12-01)

31st Annual GP<sub>2</sub>A Medicinal Chemistry Conference
od: Nicolas Primas, i dr.
Izdano: (2024-02-01)

29th Annual GP2A Medicinal Chemistry Conference
od: Jean-Jacques Helesbeux, i dr.
Izdano: (2021-12-01)

30th Annual GP<sub>2</sub>A Medicinal Chemistry Conference
od: Niamh M. O’Boyle, i dr.
Izdano: (2023-03-01)

Evaluation of Acute and Sub-Acute Toxicity, Oxidative Stress and Molecular Docking of Two Nitrofuranyl Amides as Promising Anti-Tuberculosis Agents
od: Simeon Dimitrov, i dr.
Izdano: (2023-07-01)

Molecular Insight into <em>Mycobacterium tuberculosis</em> Resistance to Nitrofuranyl Amides Gained through Metagenomics-like Analysis of Spontaneous Mutants
od: Igor Mokrousov, i dr.
Izdano: (2022-09-01)

From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases
od: LEONARDO G. FERREIRA, i dr.
Izdano: (2018-02-01)

Editorial: In silico Methods for Drug Design and Discovery
od: Simone Brogi, i dr.
Izdano: (2020-08-01)

Novel chitosan derivative based composite scaffolds with enhanced angiogenesis; potential candidates for healing chronic non-healing wounds
od: Rizwan, Muhammad, i dr.
Izdano: (2019)

Editorial: Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design, Volume II
od: Leonardo L. G. Ferreira, i dr.
Izdano: (2022-06-01)

Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics
od: Ivani Pauli, i dr.
Izdano: (2022-01-01)

An introduction to medicinal chemistry /
od: Patrick, Graham L., author
Izdano: (2013)

Copper-mediated aerobic trifluoromethyltelluration of boronic acids with [Me4N][TeCF3]
od: Jing-Yan Dong, i dr.
Izdano: (2022-12-01)

Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
od: Da Feng, i dr.
Izdano: (2022-11-01)

Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design
od: Sotirios Katsamakas, i dr.
Izdano: (2016-09-01)

Programmable selective acylation of saccharides mediated by carbene and boronic acid
od: Lv, Wen-Xin, i dr.
Izdano: (2022)

Biological therapeutics /
od: Greenstein, Ben, 1941-, i dr.
Izdano: (2011)

Chemoinformatics Strategies for Leishmaniasis Drug Discovery
od: Leonardo L. G. Ferreira, i dr.
Izdano: (2018-11-01)

Metal Complexes, an Untapped Source of Antibiotic Potential?
od: Angelo Frei
Izdano: (2020-02-01)

1st Joint European Conference on Therapeutic Targets and Medicinal Chemistry (TTMC 2015)
od: Marc Le Borgne, i dr.
Izdano: (2015-12-01)